Stock data
Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA) reported net income of -US$162.45M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$178.70M | -US$162.45M | — |
| 2024 | — | — | -US$142.26M | -US$129.47M | — |
| 2023 | — | — | -US$104.96M | -US$96.66M | — |
| 2022 | — | — | -US$106.99M | -US$104.79M | — |
| 2021 | — | — | -US$71.49M | -US$71.10M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$63.20M | — |
| 2026-03-31 | — | -US$53.09M | — |
| 2025-12-31 | — | -US$46.06M | — |
| 2025-09-30 | — | -US$42.22M | — |
| 2025-06-30 | — | -US$43.78M | — |
| 2025-03-31 | — | -US$30.39M | — |
| 2024-12-31 | — | -US$33.57M | — |
| 2024-09-30 | — | -US$34.55M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.